Black Diamond Therapeutics (BDTX) Financials: Revenue & Earnings

BDTX price $1.85 +0.10 +5.71%

Ticker
BDTX
Price
$1.85
Change
+0.10 +5.71%
Market cap ?
$106.01M
P/E ?
-2.54
Dividend yield ?
0.00%
Beta ?
3.33
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
59
Quality
46
Growth
100

Stocklytics score rationale: value 59, quality 46, growth 100.

Financials

201720182019202020212022202320242025
0000000070000000

Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal growth factor receptor…

Fair value

BDTX fair value $15.25. Price $1.85. Price is 88% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare BDTX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.06—8.33M
2026-08-05-0.17-0.20—5.56M
2026-05-07-0.16-0.18—25.00M
2026-03-16-0.26-0.18—9.38M
2025-11-06-0.15-0.22——
2025-08-07-0.19-0.25——
2025-05-120.980.0270.00M28.00M
2025-03-06-0.28-0.31——
2024-11-05-0.28-0.37——
2024-08-06-0.36-0.39——
2024-05-09-0.35-0.44——
2024-03-12-0.34-0.474.89M—
2023-11-06-0.45-0.49——
2023-08-11-0.52-0.54——
2023-05-09-0.57-0.61——
2023-03-09-0.59-0.63——
2022-11-08-0.60-0.64——
2022-08-09-0.63-0.68——
2022-05-11-0.70-0.75——
2022-03-17-0.71-1.01——
2021-11-08-0.97-0.98——
2021-08-12-0.95-0.87——
2021-05-07-0.84-0.67——
2021-03-25-0.63-0.63——
2020-11-10-0.50-0.53——
2020-08-11-0.41-0.43——
2020-05-12-0.51-0.47——
2020-03-24-4.63-1.37——
2020-02-03-0.66———
2019-06-30-0.88———
2019-03-31-0.27———
2018-12-31-0.22———
2018-09-30-1.16———
2018-06-30-0.87———
2018-03-31-0.87———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-18Behbahani AliBuy7.71K$1.9314.87K
2026-09-18Raman PrakashBuy6.80K$1.9313.13K
2026-06-26Behbahani AliBuy40.00K$1.7168.40K
2026-06-26Kulkarni SamarthBuy40.00K$1.7168.40K
2026-06-26Menzel Garry EBuy40.00K$1.7168.40K
2026-06-26Raman PrakashBuy40.00K$1.7168.40K
2026-06-26Dhingra KapilBuy40.00K$1.7168.40K
2026-06-26Campbell ShannonBuy40.00K$1.7168.40K
2026-06-19Behbahani AliBuy8.96K$1.6614.88K
2026-06-19Raman PrakashBuy7.91K$1.6613.13K
2026-03-20Behbahani AliBuy6.92K$2.1514.88K
2026-03-20Raman PrakashBuy6.11K$2.1513.13K
2026-01-21Jones ErikaBuy200.00K$2.57514.00K
2026-01-21Hatzis-Schoch BrentBuy250.00K$2.57642.50K
2026-01-21Buck ElizabethBuy250.00K$2.57642.50K
2026-01-21Yurasov SergeyBuy250.00K$2.57642.50K
2026-01-21Velleca Mark A.Buy600.00K$2.571.54M
2025-12-12Behbahani AliBuy5.21K$2.7614.37K
2025-12-12Raman PrakashBuy4.67K$2.7612.88K
2025-09-19Behbahani AliBuy4.29K$3.3514.37K
2025-09-19Raman PrakashBuy3.84K$3.3512.87K
2025-06-20Behbahani AliBuy6.17K$2.3314.38K
2025-06-20Raman PrakashBuy5.53K$2.3312.88K
2025-06-12Behbahani AliBuy30.55K$2.4374.24K
2025-06-12Menzel Garry EBuy30.55K$2.4374.24K
2025-06-12Raman PrakashBuy30.55K$2.4374.24K
2025-06-12Campbell ShannonBuy30.55K$2.4374.24K
2025-06-12Dhingra KapilBuy30.55K$2.4374.24K
2025-06-12Kulkarni SamarthBuy30.55K$2.4374.24K
2025-03-21Behbahani AliBuy7.65K$1.8814.37K
2025-03-21Raman PrakashBuy6.85K$1.8812.87K
2025-03-19BIOTECH GROWTH N VSell1.00M$2.072.07M
2025-03-19BIOTECH GROWTH N VSell300.00K$1.94582.90K
2025-03-19BIOTECH GROWTH N VSell1.00M$2.312.31M
2025-03-19BIOTECH GROWTH N VSell2.00M$2.004.00M
2025-03-19BIOTECH GROWTH N VSell400.00K$2.09837.16K
2025-03-19BIOTECH GROWTH N VSell584.29K$1.951.14M
2025-03-19BIOTECH GROWTH N VSell500.00K$2.121.06M
2025-01-30Velleca Mark A.Buy500.00K$2.521.26M
2025-01-30Velleca Mark A.Buy75.00K——
2025-01-30Yurasov SergeyBuy200.00K$2.52504.00K
2025-01-30Yurasov SergeyBuy75.00K——
2025-01-30Buck ElizabethBuy175.00K$2.52441.00K
2025-01-30Buck ElizabethBuy75.00K——
2025-01-30Jones ErikaBuy125.00K$2.52315.00K
2025-01-30Jones ErikaBuy75.00K——
2025-01-30Hatzis-Schoch BrentBuy175.00K$2.52441.00K
2025-01-30Hatzis-Schoch BrentBuy75.00K——
2024-12-13Behbahani AliBuy5.75K$2.5014.38K
2024-12-13Raman PrakashBuy5.15K$2.5012.88K
2024-12-13Campbell ShannonBuy4.50K$2.5011.25K
2024-09-20Behbahani AliBuy3.01K$4.7814.37K
2024-09-20Campbell ShannonBuy2.35K$4.7811.25K
2024-09-20Raman PrakashBuy2.69K$4.7812.88K
2024-08-28Versant Venture Capital VI, L.P.Sell221.60K$6.321.40M
2024-06-21Behbahani AliBuy2.89K$4.9814.38K
2024-06-21Raman PrakashBuy2.30K$4.9811.46K
2024-06-21Campbell ShannonBuy2.01K$4.9810.01K
2024-06-06Behbahani AliBuy30.55K$4.65142.06K
2024-06-06Kulkarni SamarthBuy30.55K$4.65142.06K
2024-06-06Menzel Garry EBuy30.55K$4.65142.06K
2024-06-06Raman PrakashBuy30.55K$4.65142.06K
2024-06-06Campbell ShannonBuy30.55K$4.65142.06K
2024-06-06Dhingra KapilBuy30.55K$4.65142.06K
2024-04-10Campbell ShannonBuy61.10K$4.98304.28K
2024-04-10Raman PrakashBuy61.10K$4.98304.28K
2024-04-10Campbell ShannonOther0——
2024-04-10Raman PrakashOther0——
2024-03-15Behbahani AliBuy3.17K$4.5414.37K
2024-03-15DIXON WENDY LBuy3.25K$4.5414.77K
2024-02-14Ni FangBuy200.00K$4.86972.00K
2024-02-14Hatzis-Schoch BrentBuy200.00K$4.86972.00K
2024-02-14Yurasov SergeyBuy225.00K$4.861.09M
2024-02-14Buck ElizabethBuy200.00K$4.86972.00K
2024-02-14Velleca Mark A.Buy537.00K$4.862.61M
2024-02-14Jones ErikaBuy100.00K$4.86486.00K
2023-12-15Behbahani AliBuy4.46K$2.7312.16K
2023-12-15DIXON WENDY LBuy4.04K$2.7311.04K
2023-10-17BIOTECH GROWTH N VBuy400.00K$2.34934.08K
2023-09-17Velleca Mark A.Buy1.00M$3.553.55M
2023-09-15Behbahani AliBuy3.30K$3.6011.88K
2023-09-15Velleca Mark A.Buy5.21K$3.6018.75K
2023-09-15DIXON WENDY LBuy2.99K$3.6010.75K
2023-07-05RA CAPITAL MANAGEMENT, L.P.Buy935.85K$5.004.68M
2023-07-05Behbahani AliBuy1.00M$5.005.00M
2023-06-30BIOTECH GROWTH N VBuy1.00M$5.005.00M
2023-06-27BIOTECH GROWTH N VBuy1.74M$5.499.56M
2023-06-27Epstein David M.Sell25.00K$6.70167.50K
2023-06-16Behbahani AliBuy5.66K$2.1011.88K
2023-06-16DIXON WENDY LBuy5.12K$2.1010.75K
2023-06-16Velleca Mark A.Buy8.93K$2.1018.75K
2023-05-16Behbahani AliBuy16.50K$1.8230.03K
2023-05-16Mayweg AlexanderBuy16.50K$1.8230.03K
2023-05-16Shah Rajeev M.Buy16.50K$1.8230.03K
2023-05-16Velleca Mark A.Buy16.50K$1.8230.03K
2023-05-16Menzel Garry EBuy16.50K$1.8230.03K
2023-05-16Kulkarni SamarthBuy16.50K$1.8230.03K
2023-05-16DIXON WENDY LBuy16.50K$1.8230.03K
2023-05-16Dhingra KapilBuy16.50K$1.8230.03K
2023-03-16Behbahani AliBuy7.11K$1.6711.88K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 103, holders -5 vs prior quarter. Ownership 61.37%.

HolderSharesChangeChange %Value
NEA MANAGEMENT COMPANY, LLC4.45M00.00%8.23M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.4.03M-6.53M-61.87%7.45M
BLACKROCK, INC.3.92M2.81M+253.90%7.25M
ACADIAN ASSET MANAGEMENT LLC2.35M00.00%4.34M
VANGUARD CAPITAL MANAGEMENT LLC2.13M274.80K+14.85%3.93M
RENAISSANCE TECHNOLOGIES LLC1.96M318.65K+19.39%3.63M
DEFILADE CAPITAL MANAGEMENT, L.P.1.67M1.67MNew3.10M
DIMENSIONAL FUND ADVISORS LP1.37M63.72K+4.90%2.53M
GEODE CAPITAL MANAGEMENT, LLC1.22M681.60K+127.03%2.25M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.1.09M34.49K+3.26%2.02M
AWM INVESTMENT COMPANY, INC.1.00M475.00K+90.48%1.85M
MARSHALL WACE, LLP896.60K60.34K+7.21%1.66M
BRIDGEWAY CAPITAL MANAGEMENT, LLC791.43K67.96K+9.39%1.46M
FMR LLC643.67K19.84K+3.18%1.19M
BALYASNY ASSET MANAGEMENT L.P.542.17K31.36K+6.14%1.00M
STATE STREET CORP525.01K311.50K+145.89%971.27K
BANK OF AMERICA CORP /DE/413.52K299.37K+262.28%765.00K
VANGUARD PORTFOLIO MANAGEMENT LLC407.07K313.89K+336.87%753.09K
NORTHERN TRUST CORP365.39K-99.31K-21.37%675.98K
BANK OF NEW YORK MELLON CORP318.76K129.62K+68.53%589.71K
VANGUARD FIDUCIARY TRUST CO309.85K49.95K+19.22%573.23K
PANAGORA ASSET MANAGEMENT INC295.17K295.17KNew546.07K
JANE STREET GROUP, LLC289.71K271.41K+1483.13%535.97K
O'SHAUGHNESSY ASSET MANAGEMENT, LLC288.87K106.64K+58.51%534.41K
GOLDMAN SACHS GROUP INC288.78K-395.64K-57.81%534.24K

Earnings and financials

Black Diamond Therapeutics, Inc. (BDTX) trades at $1.85, with a market cap of $106.01M and a trailing P/E of -2.54. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
0000000070000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Black Diamond Therapeutics (BDTX) Financials: Revenue & Earnings

BDTX$1.85+0.10 +5.71%

$106.01M

Market Cap

-2.54

P/E

—

Forward P/E

68

Score

Price History